Tunisian National Registry on Psoriasis
NCT05258838 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100
Last updated 2025-02-17
Summary
National cross-sectional multicentric study to describe the epidemiological characteristics of patients with Psoriasis in Tunisia
Conditions
Sponsors & Collaborators
-
Société Tunisienne de Dermatologie et de Vénéréologie
collaborator UNKNOWN -
Dacima Consulting
lead OTHER
Principal Investigators
-
Houda Hammami, MD · University Hospital of Habib Thameur, Ben Arous, Tunisia
-
Mohamed Denguezli, MD · University Hospital of Farhat Hached, Sousse, Tunisia
-
Asmahen Souissi, MD · [email protected]
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-12
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Tunisia
Study Locations
More Related Trials
-
Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis
NCT02798055 ·Status: COMPLETED
-
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005781 ·Status: COMPLETED
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Dermoscopy in Diagnosis of Pigmentary Skin Lesions
NCT03542539 ·Status: UNKNOWN
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT02588625 ·Status: WITHDRAWN ·Phase: PHASE2
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Assessment Of Serum And Tissue Levels Of Cold-Inducible RNA-Binding Protein In Patients With Lichen Planus
NCT06260189 ·Status: RECRUITING
-
The Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis
NCT05858099 ·Status: ACTIVE_NOT_RECRUITING
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
NCT07265999 ·Status: RECRUITING
-
COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic
NCT04451902 ·Status: UNKNOWN
-
Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
NCT03272958 ·Status: COMPLETED
-
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
NCT03253666 ·Status: COMPLETED
-
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus
NCT04356014 ·Status: UNKNOWN
-
Diabetes and Psoriasis
NCT02366273 ·Status: COMPLETED
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability
NCT07321288 ·Status: ACTIVE_NOT_RECRUITING
-
People of Color and Dermatology: A Deeper Look at Patients' Perceptions of Care and the Need for Greater Diversity in Dermatology
NCT04991285 ·Status: COMPLETED
-
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
NCT00555633 ·Status: COMPLETED
-
Role of CD7 in Skin Inflammation and Psoriasis
NCT00162825 ·Status: COMPLETED
-
Skin Denervation in Systemic Lupus Erythematosus
NCT00155532 ·Status: COMPLETED ·Phase: PHASE1
-
The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors
NCT04469582 ·Status: UNKNOWN
-
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 ·Status: COMPLETED